When stratifying the sample, according to the preoperative treatment for T2D, with or without insulin, significantly lower remission rates were determined for patients under preoperative insulin therapy and undergoing RYGB or OAGB. The gene discussed is INS; the disease is type 2 diabetes mellitus.